Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama City of Hope, Duarte, California Winship Cancer Institute, Emory University, Atlanta, Georgia Augusta Cancer Center, Augusta, Georgia University of Maryland, Baltimore, Maryland Cleveland Clinic, Cleveland, Ohio University of Texas MD Anderson Cancer Center, Houston, Texas Fred Hutchinson Cancer Research Center, Seattle, Washington Canada
Princess Margaret Cancer Centre, Toronto, Ontario